chr10-100235744-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 2P and 17B. PM2BP4_StrongBP6_Very_StrongBP7BS1
The NM_018294.6(CWF19L1):āc.1395A>Cā(p.Ala465=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000393 in 1,611,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0019 ( 0 hom., cov: 32)
Exomes š: 0.00024 ( 0 hom. )
Consequence
CWF19L1
NM_018294.6 synonymous
NM_018294.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.33
Genes affected
CWF19L1 (HGNC:25613): (CWF19 like cell cycle control factor 1) This gene encodes a member of the CWF19 protein family. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia-17 and mild cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 10-100235744-T-G is Benign according to our data. Variant chr10-100235744-T-G is described in ClinVar as [Benign]. Clinvar id is 716213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.33 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0019 (289/152354) while in subpopulation AFR AF= 0.00676 (281/41586). AF 95% confidence interval is 0.00611. There are 0 homozygotes in gnomad4. There are 147 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CWF19L1 | NM_018294.6 | c.1395A>C | p.Ala465= | synonymous_variant | 13/14 | ENST00000354105.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CWF19L1 | ENST00000354105.10 | c.1395A>C | p.Ala465= | synonymous_variant | 13/14 | 1 | NM_018294.6 | P1 | |
CWF19L1 | ENST00000478047.1 | n.1550A>C | non_coding_transcript_exon_variant | 4/5 | 2 | ||||
CWF19L1 | ENST00000468709.5 | c.*945A>C | 3_prime_UTR_variant, NMD_transcript_variant | 12/13 | 2 | ||||
CWF19L1 | ENST00000482452.5 | c.*782A>C | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00188 AC: 286AN: 152236Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
286
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000501 AC: 125AN: 249716Hom.: 0 AF XY: 0.000370 AC XY: 50AN XY: 135166
GnomAD3 exomes
AF:
AC:
125
AN:
249716
Hom.:
AF XY:
AC XY:
50
AN XY:
135166
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000236 AC: 344AN: 1459204Hom.: 0 Cov.: 29 AF XY: 0.000178 AC XY: 129AN XY: 726086
GnomAD4 exome
AF:
AC:
344
AN:
1459204
Hom.:
Cov.:
29
AF XY:
AC XY:
129
AN XY:
726086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00190 AC: 289AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.00197 AC XY: 147AN XY: 74496
GnomAD4 genome
AF:
AC:
289
AN:
152354
Hom.:
Cov.:
32
AF XY:
AC XY:
147
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 04, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at